Rockwell Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Rockwell Medical, Inc. (RMTI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-0.48-8.44-18.68-32.67-30.89-34.13-32.13
Depreciation & Amortization2.184.562.962.522.292.650.65
Stock Based Compensation1.290.930.320.940.480.000.00
Change in Working Capital-1.531.67-0.20-4.84-2.967.17-3.43
Change in Accounts Receivable2.61-4.64-0.35-1.740.030.000.00
Change in Inventory-0.331.18-2.10-0.66-1.310.000.00
Change in Accounts Payable-1.650.460.31-0.421.140.000.00
Change in Other Working Capital2.393.122.380.00-0.930.000.00
Other Operating Activities2.392.030.930.151.156.221.10
Net Cash from Operating Activities4.20-9.41-16.93-33.53-29.64-18.11-20.42
Investing Activities
Capital Expenditures-1.01-0.280.28-0.52-1.050.59-0.74
Acquisitions0.00-12.360.000.000.00-0.750.00
Purchases of Investments-5.86-5.70-21.300.834.260.000.00
Sales/Maturities of Investments2.00-5.70-2.1226.890.00-3.4113.72
Other Investing Activities0.000.000.000.000.00-41.680.00
Net Cash from Investing Activities-4.87-3.05-2.400.313.21-4.7512.72
Financing Activities
Debt Repayment-1.20-3.51-13.68-2.28-0.76-1.150.00
Common Stock Issued10.1814.8615.020.1145.470.0022.00
Common Stock Repurchased0.000.000.00-0.01-0.020.000.00
Other Financing Activities-1.630.00-0.190.00-3.88-0.28-0.06
Net Cash from Financing Activities7.3511.3416.15-2.1863.32-1.2822.00
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.00
Net Change in Cash6.68-1.12-3.18-35.4036.89-24.1414.31
Cash at Beginning of Period8.9810.1013.2848.680.0022.718.41
Cash at End of Period15.66-6.2013.2813.280.00-1.4222.71
Free Cash Flow3.19-9.41-17.21-34.06-30.69-18.70-21.41
Supplemental Disclosures
Interest Paid0.851.211.471.831.560.000.00